By what way Physician can Enhance Outcomes in Patients with metastatic Malignant Melanoma
Introduction: The incidence of malignant melanoma is increasing at a rate greater than any other human cancer. Although melanoma accounts for only 4 percent of all dermatologic cancers, it is responsible for 80 percent of deaths from skin cancer; only 14 percent of patients with metastatic melanoma...
Main Authors: | Mmohammad Erfan Zare, Ali Maleki, Mehrnoush Aeinfar, Mehrdad Payandeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2012-01-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/20889.pdf&manuscript_id=20889 |
Similar Items
-
By what way Physician can Enhance Outcomes in Patients with metastatic Malignant Melanoma
by: Mehrdad Payandeh, et al.
Published: (2012-03-01) -
Metastatic melanoma and vemurafenib: novel approaches
by: Ramon Andrade De Mello
Published: (2012-04-01) -
Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma
by: Hilal Eser Öztürk, et al.
Published: (2020-01-01) -
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
by: Castellani Elisa, et al.
Published: (2012-07-01) -
Modern options in personalized therapy of metastatic cutaneous melanoma
by: S A Protsenko, et al.
Published: (2014-09-01)